Both Semaglutide and Mounjaro represent groundbreaking methods to managing blood sugar levels, and increasingly, obesity. Tirzepatide is a combined receptor activator that impacts two chemicals involved in blood sugar control: GLP-1 and GIP. This medication, often seen as a trade name for Semaglu